The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis

This study aimed to restore the skin barrier function from atopic dermatitis (AD) via treatment with leucine-rich glioma inactivated 3 (LGI3) peptide. Male NC/Nga mice (7 weeks, 20 g) were randomly allocated into three groups (control, AD, and LGI3 group). After induction of AD skin lesions with <i>...

Description complète

Détails bibliographiques

Auteurs principaux:	Ui Seok Kim, Jin Woo Park, Eon Sub Park, Joon Seok Bang, Tae Woo Jung, Dong-Seok Kim, A. M. Abd El-Aty, Jong Hyuk Lee, Ji Hoon Jeong
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2020-08-01
Collection:	Pharmaceutics
Sujets:	atopic dermatitis leucine-rich glioma inactivated 3 (LGI3) peptide keratosis skin barrier filaggrin
Accès en ligne:	https://www.mdpi.com/1999-4923/12/8/750
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!